Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pfizer has entered into a definitive agreement to purchase Copenhagen-based Ferrosan’s consumer healthcare business from Altor 2003 Fund GP Limited.
Subscribe to our email newsletter
Ferrosan’s consumer healthcare business includes dietary supplements and lifestyle products.
Ferrosan’s portfolio of products include Multi-tabs – a multivitamin brand, Bifiform – a leading probiotic, Fri Flyt/Active Omega – an Omega 3 product, and IMEDEEN – oral skincare brands.
Ferrosan operates across Russia, the Ukraine, Poland, Turkey and many countries throughout Central and Eastern Europe.
Pfizer Consumer Healthcare president Paul Sturman said Ferrosan strengthens their presence in dietary supplements with a new set of compelling brands and product pipeline.
"The transaction will mark an important step towards expanding Ferrosan’s brands through Pfizer’s global footprint. As an immediate result of this acquisition, we will gain greater distribution and scale for Pfizer’s well-known brands such as Centrum and Caltrate in Ferrosan’s regions," Sturman said.
The transaction, which is subject to customary closing conditions, including regulatory approval in certain jurisdictions, is expected to close during the second quarter 2011.